Managing Medical Risk In Patients Seeking Psilocybin Therapy
Managing Medical Risk In Patients Seeking Psilocybin Therapy is an online, self-paced course offering healthcare providers comprehensive insights into psilocybin therapy. Gain vital knowledge about psilocybin, its legality, research indications, and learn to manage medical risks in this rapidly evolving field of psychedelic medicine.
- 50 Enrolled
- Last updated Jun '23
Managing Medical Risk In Patients Seeking Psilocybin Therapy is a comprehensive 2-hour online, CME/CE accredited course designed for healthcare providers interested in broadening their knowledge about this innovative therapeutic option. This comes in response to the emerging research on the medical benefits of psilocybin and its increased approval for medicinal uses in states like Oregon and Colorado, which have spurred a growing number of patients to consider psilocybin-assisted therapy for various health conditions.
The course aims to fill an information gap in the medical community, as many healthcare professionals have not been trained to effectively assess the medical risks associated with psilocybin therapy. This self-paced program provides participants with the tools they need to safely and comfortably evaluate and discuss the relevant medical risks with their patients.
The curriculum is structured into four key modules: ‘Background on Psilocybin’, ‘Psilocybin Legality & the Oregon Psilocybin Services Act’, ‘Research-Investigated Indications’, and ‘Managing Medical Risk in Patients Seeking Psilocybin Therapy’. These modules offer a thorough understanding of the basics of psilocybin therapy, its pharmacology, potential drug-drug interactions, the clinical indications for which it has shown promise, and contraindications to its use. It also explores the historical use of psilocybin and how it affects the mind and body.
This course is especially beneficial for primary care providers for adults and psychiatric health practitioners seeking to deepen their insights into the burgeoning field of psychedelic medicine. Upon completion, participants who pass the course are also offered the opportunity to list themselves in the PMA’s Directory of Psilocybin-Informed Clinicians, a first-of-its-kind directory. This allows patients who need a risk assessment before starting psilocybin therapy to easily find a qualified clinician and offers practitioners a unique platform to connect and share knowledge within a broader community.
What you’ll learn
- Gain a basic understanding of what psilocybin and psilocybin mushrooms are and their historical use
- Identify the indications for which psilocybin has been researched
- Understand the contraindications to psilocybin therapy and how psilocybin affects the mind and body
- Understand psilocybin’s pharmacology and drug-drug interactions
This course serves as a valuable resource, empowering healthcare providers with knowledge on psilocybin therapy and fostering a community committed to the safe and effective practice in this rapidly evolving field of medicine.
Tatayo (“Fruit of the Wind”) first arrived in Gabon in 1971 at the age of 21 and became a Gabonese citizen. In 1979, he became the first white person to be initiated into the Bwiti Fang tradition in Gabon. In 1994, he was initiated into the Misokko tradition. As a guide for numerous expeditions and missions, including those of National Geographic, the BBC, and others, Tatayo is considered to have “opened the door” to westerners in Gabon.
Frequently Asked Questions
$100For current PMA members
$375Includes PMA membership
This course includes
- Modules 4
- Duration 2 Hours
- Skills Professional
- Language English
- Availability Always
- Certificate CE